image
Intellia Therapeutics, Inc. NTLA
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 9.2
-4.17 %
$ 953 M
Market Cap
-1.76
P/E
Price Target Average
263.04%
Revenue Forecast Estimate
150.65%
EBIT Estimate
--43.80%
Net Income Estimate
41.61%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Intellia Therapeutics, Inc.
image
Wall Street analysts predict an average 1-year price target for NTLA of $33.4 , with forecasts ranging from a low of $9 to a high of $60 .
NTLA Lowest Price Target Wall Street Target
9 USD -2.17%
NTLA Average Price Target Wall Street Target
33.4 USD 263.04%
NTLA Highest Price Target Wall Street Target
60 USD 552.17%
Price
Max Price Target
Min Price Target
Average Price Target
60605050404030302020101000Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26
REVENUE FORECAST

Revenue Forecast Chart NTLA

image
$2.5b$2.5b$2.0b$2.0b$1.5b$1.5b$1.0b$1.0b$500.0m$500.0m$0.0$0.02016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart NTLA

image
$0.0$0.0($500.0m)($500.0m)($1.0b)($1.0b)($1.5b)($1.5b)($2.0b)($2.0b)($2.5b)($2.5b)2016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart NTLA

image
$1.2b$1.2b$1.0b$1.0b$800.0m$800.0m$600.0m$600.0m$400.0m$400.0m$200.0m$200.0m$0.0$0.0($200.0m)($200.0m)($400.0m)($400.0m)($600.0m)($600.0m)2016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029